Users Stopping Anti-Obesity Medications Regain Pounds Four Times Faster Than Dieters

New research suggests that patients who discontinue new slimming jabs like Wegovy and Mounjaro can put back on shed pounds far faster than those who halt conventional diet and exercise programs.

Research printed in a major medical journal points out that while overweight individuals often shed substantial amounts of their total mass while undergoing treatment, the mass returns at an average rate of nearly a kilo each month upon discontinuation.

"Users purchasing such drugs need to be aware of the danger of quick rebound weight gain when the medication is stopped," stated expert Dr. Susan Jebb.

Such speed of regain suggests a return to starting mass in about one and a half years.

Comparing Approaches

The study, which examined dozens of studies involving thousands of participants, contrasted the results of these new drugs with other pills.

Researchers point out that individuals who lose weight through dieting generally experience a more gradual creep back—around 100 grams monthly—once they finish.

Explaining the Rapid Regain

Experts propose the way of the jabs explains the amplified rebound.

These medications imitate a natural hormone called GLP-1, which helps regulate feelings of fullness.

"Long-term administration of the hormone levels several times higher than the body's typical production might result in the system to generate a reduced amount of its endogenous GLP-1, and could lessen responsiveness to its actions," said Dr. Adam Collins, a nutrition expert.

"Withdrawal of this GLP-1 'fix' leads to appetite is unsuppressed, making overeating much more probable."

A Chronic Disease?

The NHS advise the jabs for individuals with obesity-related medical conditions, accompanied by recommended diet and exercise modifications.

A number of clinicians contend that, due to the likelihood of relapse, the treatment should be considered long-term.

This view is echoed by pharmaceutical companies, who state that the results "underscore the persistent nature of obesity," akin to managing diseases like high blood pressure.

Patient Experiences

Users who have come off the medication explain a powerful return of hunger.

"It was like a switch flipping and you're instantly ravenous," recalled a patient.

This difficulty is compounded if patients have not adopted sustainable dietary or behavioural changes during therapy.

Growing Interest

Recent estimates indicate that millions of people in the UK have tried weight-loss jabs in the past year, with demand being substantial.

• Use is greater among females than men.
• The middle-aged age group shows the greatest usage rates.
• A large proportion access the medications through private prescriptions rather than public health services.

In conclusion, clinicians stress that while the jabs are effective agents for shedding pounds, they are not a permanent cure and lasting health benefits likely depends on combined lifestyle management.